PRINCETON, NJ -- (MARKET WIRE) -- February 15, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Al Altomari, Chief Operating Officer, is scheduled to provide a company update at the 19th Annual Roth Capital Partners Growth Stock Conference.
